Soichiro Hozawa

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids

Yoshihiro Kanemitsu, Hisako Matsumoto, Kenji Izuhara et al. · Journal of Allergy and Clinical Immunology · 2013 · 207 citations

Asthma, Pulmonary Circulation, Allergy +9

Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma.

Soichiro Hozawa, Yoshinori Haruta, Shinichi Ishioka et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 69 citations

Asthma, Molecular Pharmacology, Methacholine Challenge Test +13

Using Exhaled Nitric Oxide and Serum Periostin as a Composite Marker to Identify Severe/Steroid-Insensitive Asthma

Tadao Nagasaki, Hisako Matsumoto, Yoshihiro Kanemitsu et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 64 citations

Asthma, Inflammatory Lung Disease, Allergy +7

<i><scp>GLCCI</scp>1</i> variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids

Yumi Izuhara, Hisako Matsumoto, Yoshihiro Kanemitsu et al. · Allergy · 2014 · 45 citations

Asthma, Acute Lung Injury, Inflammatory Lung Disease +20